Improved time in range and postprandial hyperglycemia with canagliflozin in combination with teneligliptin: Secondary analyses of the CALMER study.

Kyu Yong Cho Hiroshi Nomoto Akinobu NakamuraShinichiro KawataHajime SugawaraJun TakeuchiSo NagaiKazuno Omori Kazuhisa Tsuchida Aika MiyaIkumi ShigesawaKenichi TsuchidaShingo YanagiyaHiraku Kameda Hiroki YokoyamaShinji TanedaYoshio KuriharaShin AokiNaoki NishimotoTatsuya AtsumiHideaki Miyoshi

Published in: Journal of diabetes investigation (2021)

Sodium-glucose cotransporter 2 inhibitor combined with dipeptidyl peptidase-4 inhibitor improved the quality of glycemic variability and reduced postprandial hyperglycemia compared with each monotherapy.

Keyphrases

blood glucose
type diabetes
randomized controlled trial
blood pressure
adipose tissue
metabolic syndrome
skeletal muscle
oxidative stress
weight loss